AxTalis news and insights

The MAP Group Unites Three Companies Under One New Brand Name, KINTIGA™

As we reflect on Tuesday’s seventh and final regional meeting

We meet with Domien Verdonck, Regulatory and Pharmacovigilance Officer, who

2025 will mark the 20th anniversary of the Small and

Join Sven and Maud at a webinar about EU HTA

Last week, our team gathered in London for our Spring

MAP Patient Access and AxTalis join forces to create a

Arthur Vanlaethemstraat 1
9050 Gentbrugge
Belgium
BE0745.587.926

RPR Gent afdeling Gent
Supervising authority for pharmacovigilance: FAMHP
(ADR@fagg.be)

M • info@axtalis.com